[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Applied Science & Performance Institute\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":92},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,54],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":34,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":42,"lastUpdatePostDateStruct":43,"startDateStruct":46,"completionDateStruct":48,"leadSponsor":50,"locationsCount":53},"100610229","the-effects-of-liquid-ivs-multi-ingredient-recovery-supplement-on-muscle-recovery-following-exercise-100610229",false,"NCT07224867","The Effects of Liquid IV's Multi-Ingredient Recovery Supplement on Muscle Recovery Following Exercise","The Effects of Liquid IV's Multi-Ingredient Recovery Supplement, on Muscle Recovery Following Exercise: A Randomized Crossover Study","Inclusion Criteria:\n\n* Healthy males or females aged 18-55 years old.\n* Must be recreationally trained or trained\u002Fdevelopmental as previously defined (McKay et al., 2021).\n* Able to read and write in English.\n* Cessation of current use of tart cherry extract, protein powders, essential amino acids\u002FBCAAs, calcium fructoborate, boron, or anabolic agents for a minimum of 1 week prior to, and throughout the duration of the study.\n* Willing to maintain regular supplement routine otherwise during the trial, and will not introduce or discontinue a supplement, other than what was previously mentioned.\n* Will not participate in any strenuous exercise for a minimum of 1-week prior to exercise performance assessments, as well as during the days of exercise testing. Strenuous exercise as defined for this study includes ½ and full marathons (or more), heavy (i.e.,\\>80% 1RM) lifting, and any high intensity, physical activity that could make your muscles sore.\n* During the study, you agree not to take any NSAIDs or other anti-inflammatory medications.\n\nExclusion Criteria:\n\n* Sedentary\n* Highly trained\u002Fnational level or professional athlete\n* Known diagnosis of any cardiovascular, metabolic, musculoskeletal, endocrine, or renal disease\u002Fdisorder.\n* Recent musculoskeletal injury (\\\u003C3-months)\n* Recent orthopedic surgery (\\\u003C12-months)\n* History or current malignancy.\n* Current respiratory infection (i.e., cold) or high temperature (fever) within the past 4-weeks.\n* Previous gastrointestinal surgery within the past 12 months.\n* Regular smoker.\n* Regular drinker (\\>14 drinks per week).\n* Those regularly using anti-inflammatory drugs within the last 4-weeks.\n* Current use of prescription medications that may influence adaptation to exercise (hormone therapies, peptides, etc.).\n* Allergies to study-related materials.\n* Any condition that impairs their ability to complete the required exercises.\n* Female subjects must not be pregnant or lactating.\n* Are unable to provide informed consent or are non-English speakers.\n* Presently using GLP-1 medications.",true,"ALL","18 Years","55 Years",{"count":21,"type":22},30,"ESTIMATED","INTERVENTIONAL",[25],"NA","The purpose of this study is to evaluate the efficacy of a multi-ingredient recovery supplement . The research will focus on strength recovery and performance maintenance assessing reductions in soreness and inflammation, as well as muscle repair and damage mitigation. By investigating these key recovery metrics, this study aims to investigate the efficacy of this supplement as a solution for active individuals seeking to optimize post-exercise recovery.",[28,29,30,31,32,33],"Muscle Damage","Strength Recovery","Perceived Recovery","Perceived Muscle Soreness","Physical Performance","Muscle Recovery",[35,36,37,38,39,40],"muscle damage","muscle recovery","strength recovery","physical performance","perceived recovery","perceived muscle soreness","NOT_YET_RECRUITING","2026-04-06",{"date":44,"type":45},"2026-04-09","ACTUAL",{"date":47,"type":22},"2026-05-01",{"date":49,"type":22},"2026-10-01",{"name":51,"class":52},"Applied Science & Performance Institute","INDUSTRY",1,{"id":55,"slug":56,"hasResults":11,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":4,"eligibilityCriteria":60,"healthyVolunteers":16,"sex":17,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":4,"studyType":23,"phases":65,"briefSummary":66,"conditions":67,"keywords":73,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":53},"100631047","the-acute-effects-of-onnit-alpha-brain-on-cognition-and-mood-states-100631047","NCT07495592","The Acute Effects of Onnit Alpha Brain on Cognition and Mood States","The Acute Effects of Onnit Alpha Brain on Cognition and Mood States: A Randomized, Crossover, Double Blind, Placebo-Controlled Trial","Inclusion Criteria:\n\n* Healthy males and females aged 20-59\n* Free of chronic diseases.\n* Able to read and write in English\n* Willing to maintain a habitual diet, supplement routine, and avoid other lifestyle changes during the study period\n* Willingness to meet all study requirements and restrictions. Including willing to arrive in lab in a sleep deprived state (\\\u003C or =5 hours), willing to avoid alcohol consumption 72 hours prior to testing days, and willing to avoid caffeine within 12 hours prior to testing days.\n\nExclusion Criteria:\n\n* Habitual high caffeine consumers (\\> 400 mg\u002Fday) assessed through caffeine assessment tool (Caffeine Consumption Questionnaire, CCQ)\n* Unwilling to wear sleep monitor at night\n* Known diagnosis of any cognitive impairment, cardiovascular, metabolic, endocrine, or renal disease\n* Has fever, or cold like symptoms\n* History of anxiety disorders\n* History of sleep disorders (i.e., insomnia), and habitually short sleepers (\\\u003C5 hours of sleep nightly)\n* History or current malignancy\n* Previous gastrointestinal surgery within the past 12 months\n* No alcohol consumption 72 hours prior to the start of the study\u002Fconsumption of the study product and during the testing days\n* No caffeine consumption within 12 hours prior to the start of the study and during the testing days\n* Sleep medicines, melatonin, or marijuana within 1 week of the start of the study\n* Regular smoker\n* Regular drinker (\\>14 drinks per week)\n* Current use (within the past 4 weeks) of dietary supplements or prescription medicines that may enhance cognitive performance (including, but not limited to L-Theanine, Cat's claw bark extract, Alpha GPC, Toothed clubmoss extract (Huperzine A), Bacopa, Phosphatidylserine, Paraxanthine, Pterostilbene, and Sceletium tortuosum).\n* Current use of prescription medications that may influence cognition (hormone therapies, peptides, etc.)\n* Travel involving time zone change, shift work, or other life events that alter sleep schedule \\>3 hours from the norm one week before the start of the study\n* Any subject with a condition deemed by the investigator or sponsor to potentially interfere with study participation\n* Women who have been pregnant within the past 6-months, are breastfeeding, lactating, or presently planning to become pregnant during the duration of the study","20 Years","59 Years",{"count":64,"type":22},34,[25],"The purpose of this randomized, double-blind, placebo-controlled crossover study is to evaluate the efficacy of the acute effects of an investigational supplement (Alpha Brain or Alpha Brain 2.0) on improving cognitive performance, vigilance, and subjective mood in healthy adults compared to placebo during a period of acute sleep deprivation under conditions of controlled sleep deprivation.",[68,69,70,71,72],"Cognitive","Mood and Cognitive Performance","Sleep Deprivation","Executive Function (Cognition)","Fatigue",[74,75,76,77,78,79,80,81,82,83],"Alpha Brain","Dietary Supplement","Reaction Time","Attention","Vigilance","Mood States","Psychomotor Vigilance Test","Stroop Test","alertness","Executive Function","2026-03-30",{"date":86,"type":45},"2026-04-03",{"date":88,"type":22},"2026-04-16",{"date":90,"type":22},"2026-08-15",{"name":51,"class":52},""]